Explore
13D/13G Activist Filings
121,593 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | XNET | Xunlei Limited | Shenglong Zou ("Mr. Zou") | 13G/A | 5.5% | 17.2M |
| Nov 14, 2025 | OKYO | OKYO Pharma Ltd | Dauntless Investment Group, LLC | 13G/A | 6.3% | 2.4M |
| Nov 14, 2025 | TVTX | TRAVERE THERAPEUTICS, INC | JANUS HENDERSON GROUP PLC | 13G/A | 11.9% | 10.6M |
| Nov 14, 2025 | MNPR | MONOPAR THERAPEUTICS INC | JANUS HENDERSON GROUP PLC | 13G/A | 19.5% | 1.3M |
| Nov 14, 2025 | MAZE | MAZE THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 7.3% | 3.2M |
| Nov 14, 2025 | LXEO | LEXEO THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 11.3% | 6.1M |
| Nov 14, 2025 | N/A | KAZIA THERAPEUTICS LTD | Dauntless Investment Group, LLC | 13G/A | 9.9% | 177K |
| Nov 14, 2025 | GUTS | FRACTYL HEALTH, INC. | SilverArc Capital Management, LLC | 13G | 8.0% | 10.6M |
| Nov 14, 2025 | FEMY | FEMASYS INC | Dauntless Investment Group, LLC | 13G/A | 9.9% | 4.4M |
| Nov 14, 2025 | NSPR | InspireMD, Inc. | Parkman Healthcare Partners LLC | 13G | 5.8% | 2.4M |
| Nov 14, 2025 | LGND | LIGAND PHARMACEUTICALS INCORPORATED | JANUS HENDERSON GROUP PLC | 13G/A | 5.3% | 1.0M |
| Nov 14, 2025 | SXT | SENSIENT TECHNOLOGIES CORPORATION | JANUS HENDERSON GROUP PLC | 13G/A | 5.4% | 2.3M |
| Nov 14, 2025 | N/A | RENTOKIL INITIAL PLC | JANUS HENDERSON GROUP PLC | 13G/A | 5.6% | 142.4M |
| Nov 14, 2025 | ARDX | ARDELYX, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 5.7% | 13.8M |
| Nov 14, 2025 | OSIS | OSI SYSTEMS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 5.9% | 1.0M |
| Nov 14, 2025 | CDAY | DAYFORCE, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 6.0% | 9.4M |
| Nov 14, 2025 | AVTX | Avalo Therapeutics, Inc. | SilverArc Capital Management, LLC | 13G | 5.5% | 721K |
| Nov 14, 2025 | RVMD | REVOLUTION MEDICINES, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 6.1% | 11.4M |
| Nov 14, 2025 | ASUR | ASURE SOFTWARE INC | JANUS HENDERSON GROUP PLC | 13G/A | 6.1% | 1.7M |
| Nov 14, 2025 | DAO | Youdao, Inc. | Orbis Investment Management Limited | 13G/A | 23.3% | 7.3M |
| Nov 14, 2025 | PKI | REVVITY, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 6.6% | 7.6M |
| Nov 14, 2025 | RXO | RXO, Inc. | Orbis Investment Management Limited | 13G/A | 19.3% | 31.6M |
| Nov 14, 2025 | QXO | QXO, Inc. | ORBIS INVESTMENT MANAGEMENT LTD | 13G/A | 12.6% | 85.0M |
| Nov 14, 2025 | PTLO | Portillo's Inc. | ORBIS INVESTMENT MANAGEMENT LTD | 13G/A | 9.5% | 6.8M |
| Nov 14, 2025 | NBIS | Nebius Group N.V. | Orbis Investment Management Limited | 13G/A | 5.9% | 12.8M |
| Nov 14, 2025 | BNR | Burning Rock Biotech Ltd | Kynam Capital Management, LP | 13G/A | 11.0% | 995K |
| Nov 14, 2025 | NCMI | National CineMedia, Inc. | ORBIS INVESTMENT MANAGEMENT LTD | 13G | 5.6% | 5.2M |
| Nov 14, 2025 | SSNC | SS&C TECHNOLOGIES HOLDINGS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 6.8% | 16.5M |
| Nov 14, 2025 | MCS | Marcus Corp | Orbis Investment Management Limited | 13G/A | 7.2% | 1.8M |
| Nov 14, 2025 | ST | SENSATA TECHNOLOGIES HOLDING PLC | JANUS HENDERSON GROUP PLC | 13G/A | 6.9% | 10.1M |
| Nov 14, 2025 | FLEX | FLEX LTD. | JANUS HENDERSON GROUP PLC | 13G/A | 7.0% | 26.3M |
| Nov 14, 2025 | COGT | Cogent Biosciences, Inc. | Kynam Capital Management, LP | 13G/A | 5.5% | 7.9M |
| Nov 14, 2025 | GIL | GILDAN ACTIVEWEAR INC | JANUS HENDERSON GROUP PLC | 13G/A | 7.0% | 10.5M |
| Nov 14, 2025 | IDYA | IDEAYA BIOSCIENCES, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 7.3% | 6.4M |
| Nov 14, 2025 | SLMT | Brera Holdings PLC | Qube Research & Technologies Ltd | 13G | 9.8% | 6.5M |
| Nov 14, 2025 | IMAX | IMAX CORP | Orbis Investment Management Limited | 13G/A | 9.7% | 5.2M |
| Nov 14, 2025 | ZNB | ZETA NETWORK GROUP | Anson Funds Management LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | GXO | GXO Logistics, Inc. | Orbis Investment Management Limited | 13G/A | 11.5% | 13.1M |
| Nov 14, 2025 | N/A | GENMAB A/S | ORBIS INVESTMENT MANAGEMENT LTD | 13G | 5.8% | 3.7M |
| Nov 14, 2025 | REZI | Resideo Technologies, Inc. | Fuller & Thaler Asset Management, Inc. | 13G/A | 4.2% | 6.3M |
| Nov 14, 2025 | CRSP | CRISPR Therapeutics AG | ORBIS INVESTMENT MANAGEMENT LTD | 13G | 5.5% | 5.0M |
| Nov 14, 2025 | MODD | Modular Medical, Inc. | 683 Capital Management, LLC | 13G/A | 3.3% | 1.9M |
| Nov 14, 2025 | INSE | Inspired Entertainment, Inc. | 683 Capital Management, LLC | 13G/A | 4.2% | 1.1M |
| Nov 14, 2025 | FLT | Corpay, Inc. | Orbis Investment Management Limited | 13G/A | 5.7% | 4.0M |
| Nov 14, 2025 | AVBC | AVIDIA BANCORP INC | T. Rowe Price Investment Management, Inc. | 13G | 6.1% | 1.2M |
| Nov 14, 2025 | CNK | Cinemark Holdings, Inc | Orbis Investment Management Limited | 13G/A | 9.8% | 11.4M |
| Nov 14, 2025 | PODC | PodcastOne, Inc. | Galloway Capital Partners, LLC | 13D/A | 3.1% | 832K |
| Nov 14, 2025 | RNA | AVIDITY BIOSCIENCES INC | T. Rowe Price Associates, Inc. | 13G/A | 7.1% | 9.8M |
| Nov 14, 2025 | BBOT | BridgeBio Oncology Therapeutics Inc | T. Rowe Price Associates, Inc. | 13G | 1.1% | 885K |
| Nov 14, 2025 | GLUE | MONTE ROSA THERAPEUTICS INC | T. Rowe Price Associates, Inc. | 13G/A | 7.5% | 4.6M |